Lupin launches its Acticlate generic
BALTIMORE — Lupin has introduced its generic of Acticlate (doxycycline hyclate) tablets. The drug is indicated to treat and prevent various infections and as an adjunctive severe acne treatment.
Lupin’s generic will be available in 75- and 150-mg dosage strengths. The product had U.S. sales of $263 million for the 12 months ended June 2017, according to QuintilesIMS data.